Inhaltsverzeichnis
Auswahl der wissenschaftlichen Literatur zum Thema „Therapeutic use“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Therapeutic use" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Therapeutic use"
Neekhra, Sachin, Himani Awasthi und DCP Singh. „Potential Therapeutic use of Streblus asper: A Review“. International Journal of Research and Development in Pharmacy & Life Sciences 6, Nr. 7 (Dezember 2017): 2845–49. http://dx.doi.org/10.21276/ijrdpl.2278-0238.2017.6(7).2845-2849.
Der volle Inhalt der QuelleDvorak, J. „Therapeutic use exemption“. British Journal of Sports Medicine 40, Supplement 1 (01.07.2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.
Der volle Inhalt der QuelleNadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince und J. E. Bowen. „THERAPEUTIC MODALITY USE“. Medicine & Science in Sports & Exercise 33, Nr. 5 (Mai 2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.
Der volle Inhalt der QuellePradhan, Leena, Nicholas D. Andersen, Christoph Nabzdyk, Frank W. LoGerfo und Aristidis Veves. „Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions“. US Endocrinology 00, Nr. 01 (2007): 68. http://dx.doi.org/10.17925/use.2007.00.1.68.
Der volle Inhalt der QuelleGallagher, Lisa M., und Francois Bethoux. „Therapeutic use of the Arts for Patients with Multiple Sclerosis“. US Endocrinology 13, Nr. 02 (2017): 82. http://dx.doi.org/10.17925/use.2017.13.02.82.
Der volle Inhalt der QuelleGroeneweg, Stefan, Robin P. Peeters, Theo J. Visser und W. Edward Visser. „Diagnostic and Therapeutic Challenges in the Allan—Herndon—Dudley Syndrome“. US Endocrinology 12, Nr. 02 (2016): 90. http://dx.doi.org/10.17925/use.2016.12.02.90.
Der volle Inhalt der QuelleTan, Robert S., Chris Ojeih und Maurita Carrejo. „Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism“. US Endocrinology 00, Nr. 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1a.
Der volle Inhalt der QuelleTan, Robert S., Chris Ojeih und Maurita Carrejo. „Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism“. US Endocrinology 00, Nr. 01 (2005): 84. http://dx.doi.org/10.17925/use.2005.00.01.84.
Der volle Inhalt der QuelleRodriguez, Mariano, Juan Munoz-Castaneda und Yolanda Almaden. „Therapeutic Use of Calcitriol“. Current Vascular Pharmacology 12, Nr. 2 (April 2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.
Der volle Inhalt der QuelleWall, Jenny, Sally Davis und Samantha Ridgway. „Cannabis: its therapeutic use“. Nursing Standard 16, Nr. 10 (21.11.2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.
Der volle Inhalt der QuelleDissertationen zum Thema "Therapeutic use"
Xiang, Hong. „Effects of myo-inositol and, or triiodothyronine (T₃) treatment on cardiac dysfunction and elevated myocardial lipid levels in STZ-diabetic rats“. Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26675.
Der volle Inhalt der QuellePharmaceutical Sciences, Faculty of
Graduate
Ramez-Baydoun, Lubna Lulu. „Novel chelating agents for therapeutic use“. Thesis, King's College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.406043.
Der volle Inhalt der QuelleMarnewick, Jeanine Lucasta. „Cancer modulating properties of unique South African herbal teas (rooibos and honeybush) in short term in vitro and in vivo carcinogenesis assays“. Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/21888.
Der volle Inhalt der QuelleENGLISH ABSTRACT: This thesis provides the first scientific evidence on the cancer modulating properties of two unique South African herbal teas, rooibos (Aspalathus Iinearis) and honeybush (Cyclopia intermedia) utilizing in vitro as well as in vivo carcinogenesis assays by: • Demonstrating the in vitro antimutagenic activity of aqueous extracts of the herbal teas against the metabolic activated mutagens, 2-acetylaminofluorene (2- AAF) and the mycotoxin, aflatoxin B1 (AFB,) as well as, to a certain extent, against the direct acting mutagen, hydrogen peroxide, utilizing the Salmonella typhimurium mutagenicity assay. • Increasing the activity of hepatic drug metabolizing enzymes, glutathione Stransferase alpha and UPD-glucuronosyl transferase, and reduced the oxidative stress by stabilizing the level of reduced glutathione (GSH) resulting in an increased hepatic reduced to oxidized glutathione ratio (GSG:GSSG). No toxic effects were noticed in rats consuming the herbal teas for 10 weeks as their sole source of drinking fluid. • Demonstrating the ex vivo modulation of 2-AAF- and AFB1-induced mutagenesis by sub- cellular hepatic fractions of rats consuming the herbal teas in the Salmonella mutagenicity assay. Hepatic cytosolic fractions protected against mutagenesis of both mutagens, while the microsomal fractions exhibited a reduced capacity to metabolize AFB1 to its active mutagenic metabolite. • Providing evidence for the in vivo modulation of tumour promotion using the liver as well as the two-stage skin carcinogenesis animal models. The unprocessed herbal teas arrested proliferation of the placental form of glutathione-Stransferase (GSTP+) altered cells as well as reduced the total number of enzyme altered foci in the liver of rats. Topical application of polyphenolic fractions of the various herbal teas prior to 12-0-tetra-decanoylphorbol-13-acetate (TPA) tumour promotion, reduced tumour formation in mouse skin initiated with 7,12-dimethylbenz[ ajanthracene (DMBA). The protective effect was illustrated by a decreased tumour incidence, a reduction in tumour volume as well as a delayed onset of tumour development. The f1avanol/proanthocyanidin content of the fractions could playa major role in the protection against skin tumour promotion. • Proposing possible mechanisms whereby rooibos and honeybush herbal teas could exert their cancer modulating properties with respect to in vitro and ex vivo antimutagenicity, in vivo oxidative status and reduced tumour promotion. • Providing evidence that the herbal teas mimic the cancer modulating properties of green and black teas although differences exist, presumably due to differences in the polyphenolic constituents. • Suggesting that rooibos and honeybush herbal teas may play an important role as chemopreventive agents in the modulation of cancer.
AFRIKAANSE OPSOMMING: Hierdie tesis bevat die eerste ondersoek na die effek van waterige en polifenoliese ekstrakte van rooibos (Aspalathus Iinearis) en heuningbos (Cyclopia intermedia) op verskeie aspekte van kankerontwikkeling. Die twee kruietees is uniek aan Suid-Afrika en kan 'n belangrike rol speel in die voorkoming van kanker. Verskillende in vitro so wei as in vivo studies het die volgende getoon: • Antimutageniese aktiwiteite teen die metabolies-geaktiveerde mutagene, 2- asetielaminofluoreen (2-AAF) en die mikotoksien, aflatoksien B1 (AFB1) in die Salmonella fyphimurium mutagenisiteitstoets. 'n Beperkte mate van beskerming is ook verleen teen die oksidatiewe mutageen, waterstofperoksied, sonder metaboliese aktivering. • Verhoogde aktiwiteite van die fase II ensieme, glutatioon S-tranferase alfa en UDP-glukuronidase, wat liggaamsvreemde verbindings metaboliseer. Die kruietees verlaag die oksidasietoestand soos weerspieel word deur 'n toename van gereduseerde glutatioon tot die geoksideerde vorm in die lewer van rotte wat 10 weke hierdie kruietees gedrink he!. Die kruietees het geen toksiese uitwerking op die rotte gehad nie. • Antimutageniese aktiwiteite van subselluiE~re fraksies van die lewer teenoor 2- AAF en AFB1 in die Salmonella toets. Die sitosolfraksie van die rotlewer bied beskerming teen die ge"induseerde mutagenese van beide mutagene, terwyl die mikrosomale fraksie ook die metaboliese aktivering van AFB1 na die aktiewe mutageniese metaboliet verminder. • In vivo modulering van kankerpromosie met behulp van bekende rotlewer en muisvel kankerontwikkelingsmodelle. In die lewermodel het die ongeprosesseerde kruietees beide die ontwikkeling en getal van GSTP+ fokusse onderskeidelik vertraag en verminder. In die geval van die velkankermodel het aanwending van polifenoliese fraksies van die kruietees beskerming gebied teen die ontwikkeling van velkankers by muise. Die aantal en grootte van die tumors het afgeneem terwyl die verskyning daarvan ook vertraag is. • Verskeie meganismes waardeur rooibos- en heuningboslee moonllik kanker kan moduleer word voorgeslel. Verskille in die polifenoliese sameslelling asook hul onderskeie konsenlrasies kan 'n belangrike rol speel in die kankerveranderende effekle van die lees. • Oal gereelde inname van rooibos- en/of heuningboslee moonllik 'n belangrike rol kan speel in die voorkoming van dieel- en omgewings-geYnduseerde kankers.
Cheng, Ka-wing, und 鄭家榮. „Preventive potential and mechanism of dietary phenolics on the formation of mutagenic heterocyclic amines“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B4284177X.
Der volle Inhalt der Quellepublished_or_final_version
Biological Sciences
Doctoral
Doctor of Philosophy
Stapleton, Graham Neil. „A study of the effects of sucralfate in the bile duct litigated pig peptic ulcer model with particular reference to the effects on the physico-chemical properties of gastric mucus and including comparisons with famotidine and misoprostol“. Master's thesis, University of Cape Town, 1992. http://hdl.handle.net/11427/25727.
Der volle Inhalt der QuelleBetz, Jennifer. „The Use of Improvisation in Therapeutic Practices“. Kent State University Honors College / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ksuhonors1557312650223249.
Der volle Inhalt der QuelleParsons, Ann Bernardene. „Designing a resource guide for horticultural therapy programs at botanical gardens and arboreta“. Thesis, Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/104531.
Der volle Inhalt der Quelle余詩德 und Sze-tak Yu. „Effects of Chinese green tea and tea catechins on lipolysis“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1999. http://hub.hku.hk/bib/B31969677.
Der volle Inhalt der QuelleZhang, Jingjing, und 张晶晶. „The anti-cancer properties of cyclometalated gold(III) complexes and organogold(III) supramolecular polymers“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/208171.
Der volle Inhalt der Quellepublished_or_final_version
Chemistry
Doctoral
Doctor of Philosophy
Roberts, Jacintha. „Studies on bisphosphonate elution from orthopaedic implants“. Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112582.
Der volle Inhalt der QuelleBücher zum Thema "Therapeutic use"
Jens, Kurreck, Hrsg. Therapeutic oligonucleotides. Cambridge, UK: RSC Pub., 2008.
Den vollen Inhalt der Quelle findenRaphael, Mechoulam, Hrsg. Cannabinoids as therapeutic agents. Boca Raton, Fla: CRC Press, 1986.
Den vollen Inhalt der Quelle findenTekinay, Ayse B., und Mustafa Ö. Güler. Therapeutic nanomaterials. Hoboken, New Jersey: John Wiley & Sons, Inc., 2016.
Den vollen Inhalt der Quelle findenLabate, Beatriz Caiuby, und Clancy Cavnar, Hrsg. The Therapeutic Use of Ayahuasca. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-40426-9.
Der volle Inhalt der QuelleWosket, Val. The Therapeutic Use of Self. Classic edition. | Milton Park, Abingdon, Oxon ;: Routledge, 2016. http://dx.doi.org/10.4324/9780203772263.
Der volle Inhalt der QuelleMackway-Girardi, AnnMarie. Therapeutic use of interleukin-2. Bethesda, MD: U.S. DHHS, PHS, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1991.
Den vollen Inhalt der Quelle findenM, Sondel Paul, und International Cancer Research Data Bank., Hrsg. Therapeutic use of interleukin-2. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1992.
Den vollen Inhalt der Quelle findenNath, Dwivedi Kedar, Hrsg. The therapeutic use of stories. London: Routledge, 1997.
Den vollen Inhalt der Quelle findenYuti, Chernajovsky, und Nissim Ahuva, Hrsg. Therapeutic antibodies. Berlin: Springer, 2007.
Den vollen Inhalt der Quelle findenBéla, Scheiber, und Selby Carla, Hrsg. Therapeutic touch. Amherst, N.Y: Prometheus Books, 2000.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Therapeutic use"
Read, Daniel, James Skinner, Daniel Lock und Aaron CT Smith. „Therapeutic use exemptions“. In WADA, the World Anti-Doping Agency, 102–23. First. | Milton Park, Abingdon, Oxon ; New York NY : Routledge, 2021. | Series: Routledge research in sport and corruption: Routledge, 2021. http://dx.doi.org/10.4324/9781003084297-6-6.
Der volle Inhalt der QuelleSelekman, Matthew D. „Therapeutic Brick Walls“. In The Therapist’s Use of Self, 110–40. New York: Routledge, 2023. http://dx.doi.org/10.4324/9781003334460-5.
Der volle Inhalt der QuelleWiltenburg, Victor Distefano, Dianne da Rocha Prado und Fúlvio Rieli Mendes. „Therapeutic Use of Hallucinogens“. In Drugs and Human Behavior, 479–510. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62855-0_35.
Der volle Inhalt der QuelleLanzotti, Virginia. „Diterpenes for Therapeutic Use“. In Natural Products, 3173–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-22144-6_192.
Der volle Inhalt der QuelleFroehlich, Jan. „Therapeutic Use of Self“. In Occupational Therapy Essentials for Clinical Competence, 133–47. 3. Aufl. New York: Routledge, 2024. http://dx.doi.org/10.4324/9781003525295-12.
Der volle Inhalt der QuellePolatajko, Helene J., Jane A. Davis und Sara E. McEwen. „Therapeutic Use of Self“. In Occupational Therapy, 81–92. 4. Aufl. Boca Raton: Routledge, 2024. http://dx.doi.org/10.4324/9781003522997-7.
Der volle Inhalt der QuelleAranki, S. F., F. Mannting, S. K. Shernan, N. C. Cummings, S. P. Sears und L. H. Cohn. „Transmyocardial Laser Use for Endstage Coronary Artery Disease“. In Therapeutic Angiogenesis, 163–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-03776-8_9.
Der volle Inhalt der QuelleChugh, Atul R., Samir N. Patel, Venkataraman Rajaram, Rachel Neems, Matt Feinstein, Marshall Goldin und Steven B. Feinstein. „The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis“. In Therapeutic Lipidology, 389–408. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_18.
Der volle Inhalt der QuelleTorres-Gómez, Mariano. „Human Medicinal Mushroom Use“. In Therapeutic Mushrooms for Diabetes Mellitus, 35–66. New York: Apple Academic Press, 2023. http://dx.doi.org/10.1201/9781003332046-3.
Der volle Inhalt der QuelleBartolomei, Mirco, und Giovanni Paganelli. „Intracavitary Use of Radionuclides and Treatment of Meningiomas“. In Therapeutic Nuclear Medicine, 207–14. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/174_2012_693.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Therapeutic use"
Fikar, Peter, Florian Güldenpfennig und Roman Ganhör. „The Use(fulness) of Therapeutic Toys“. In DIS '18: Designing Interactive Systems Conference 2018. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3196709.3196721.
Der volle Inhalt der QuelleDahl, Elizabeth. „Towards the use of HIFU, in Conjunction with Surgery, in the Treatment of Malignant Brain Tumors“. In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205469.
Der volle Inhalt der QuelleMcLaughlan, James. „The Design And Implementation Of A Passive Cavitation Detection System For Use With Ex Vivo Tissue“. In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205493.
Der volle Inhalt der QuelleBaldaque-Silva, F., J. P. Pereira, V. Miroslav, W. Naining und M. Omae. „Are single use endoscopes suitable for therapeutic endoscopy?“ In ESGE Days 2024. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1783510.
Der volle Inhalt der QuelleBera, Jean-Christophe, Bruno Gilles, Izella Saletes, Claude Inserra und Hiva Shamsborhan. „Numerical study of cavitation threshold by use of bifrequency excitation“. In 11TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2012. http://dx.doi.org/10.1063/1.4757304.
Der volle Inhalt der QuellePayne, A., A. Blankespoor, N. Todd, U. Vyas, D. Christensen, D. Parker, R. Roemer und Emad S. Ebbini. „Optimization of HIFU Treatments for Use in Model Predictive Control“. In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131406.
Der volle Inhalt der QuelleKaneko, Yukio. „The Design Of Microbubbles Specialized For Therapeutic Or Diagnostic Use“. In 4TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2005. http://dx.doi.org/10.1063/1.1901643.
Der volle Inhalt der QuelleWong, Serena H., Ronald D. Watkins, Mario Kupnik, Kim Butts Pauly, B. T. Khuri-Yakub und Emad S. Ebbini. „Progress in Development of HIFU CMUTs for use under MR-guidance“. In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131441.
Der volle Inhalt der QuellePayne, Allison H., Dennis L. Parker, Jeff Moellmer, Robert B. Roemer und Sarah Clifford. „Characterization of an Isolated Kidney’s Vasculature for Use in Bio-Thermal Modeling“. In 6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2007. http://dx.doi.org/10.1063/1.2744297.
Der volle Inhalt der QuelleAmato, Federica, Marianna Di Gregorio, Clara Monaco, Monica Sebillo, Genoveffa Tortora und Giuliana Vitiello. „The Therapeutic Use of Humanoid Robots for Behavioral Disorders“. In AVI '20: International Conference on Advanced Visual Interfaces. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3399715.3399960.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Therapeutic use"
Evans, Holly. The Use of Filariae as a Therapeutic Agent for Hypersensitivity Diseases. Fort Belvoir, VA: Defense Technical Information Center, November 2014. http://dx.doi.org/10.21236/ad1012825.
Der volle Inhalt der QuelleLillo, Antonietta. Harnessing in vitro evolution to discover antibodies for therapeutic and diagnostic use. Office of Scientific and Technical Information (OSTI), März 2021. http://dx.doi.org/10.2172/1773320.
Der volle Inhalt der QuelleBaldi, Emilio. The Use of Extremely Low Frequencies (ELF) in Pulsed Form (PELF) for Therapeutic Use: A Pilot Study. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2001. http://dx.doi.org/10.21236/ada409410.
Der volle Inhalt der QuelleTempleton, Charles B., Mark A. Poli und Rikki Solow. Prophylactic and Therapeutic Use of an Anti-Brevetoxin (PbTx-2) Antibody in Conscious Rats. Fort Belvoir, VA: Defense Technical Information Center, Mai 1988. http://dx.doi.org/10.21236/ada210932.
Der volle Inhalt der QuelleO'Keefe, Denise S., und Warren D. Heston. Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies Against Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, Juni 2002. http://dx.doi.org/10.21236/ada407353.
Der volle Inhalt der QuelleKlimas, Nancy G., und Mary A. Fletcher. The Use of Comprehensive Molecular Profiling With Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, Juli 2010. http://dx.doi.org/10.21236/ada529400.
Der volle Inhalt der QuelleKlimas, Nancy G., und Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, Juli 2012. http://dx.doi.org/10.21236/ada568442.
Der volle Inhalt der QuelleKlimas, Nancy G., und Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, Juli 2011. http://dx.doi.org/10.21236/ada554188.
Der volle Inhalt der QuelleSentcоv, Valentin, Andrei Reutov und Vyacheslav Kuzmin. Electronic training manual "Acute drug poisoning". SIB-Expertise, Januar 2024. http://dx.doi.org/10.12731/er0776.29012024.
Der volle Inhalt der QuelleAlbuquerque, Nila, Franklin Regis und Lucas Machado. Analysis of effectiveness, costs, quality of life, adherence and safety of the use of adalimumab in adults diagnosed with moderate to severe hidradenitis suppurativa: systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Oktober 2021. http://dx.doi.org/10.37766/inplasy2021.10.0010.
Der volle Inhalt der Quelle